NVCT
Price
$7.72
Change
+$0.01 (+0.13%)
Updated
Dec 26, 04:59 PM (EDT)
Capitalization
197.49M
73 days until earnings call
Intraday BUY SELL Signals
RGNX
Price
$14.16
Change
-$0.30 (-2.07%)
Updated
Dec 26, 04:59 PM (EDT)
Capitalization
732.01M
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NVCT vs RGNX

Header iconNVCT vs RGNX Comparison
Open Charts NVCT vs RGNXBanner chart's image
Nuvectis Pharma
Price$7.72
Change+$0.01 (+0.13%)
Volume$878
Capitalization197.49M
REGENXBIO
Price$14.16
Change-$0.30 (-2.07%)
Volume$4.87K
Capitalization732.01M
NVCT vs RGNX Comparison Chart in %
NVCT
Daily Signal:
Gain/Loss:
RGNX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NVCT vs. RGNX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCT is a Buy and RGNX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (NVCT: $7.71 vs. RGNX: $14.46)
Brand notoriety: NVCT and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVCT: 13% vs. RGNX: 31%
Market capitalization -- NVCT: $197.49M vs. RGNX: $732.01M
NVCT [@Biotechnology] is valued at $197.49M. RGNX’s [@Biotechnology] market capitalization is $732.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCT’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • NVCT’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, both NVCT and RGNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCT’s TA Score shows that 6 TA indicator(s) are bullish while RGNX’s TA Score has 5 bullish TA indicator(s).

  • NVCT’s TA Score: 6 bullish, 4 bearish.
  • RGNX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both NVCT and RGNX are a good buy in the short-term.

Price Growth

NVCT (@Biotechnology) experienced а +1.72% price change this week, while RGNX (@Biotechnology) price change was +9.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.37%. For the same industry, the average monthly price growth was +0.28%, and the average quarterly price growth was +55.43%.

Reported Earning Dates

NVCT is expected to report earnings on Mar 10, 2026.

RGNX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($732M) has a higher market cap than NVCT($197M). RGNX YTD gains are higher at: 87.063 vs. NVCT (42.514). NVCT has higher annual earnings (EBITDA): -26.41M vs. RGNX (-120M). RGNX has more cash in the bank: 274M vs. NVCT (35.4M). RGNX has higher revenues than NVCT: RGNX (161M) vs NVCT (0).
NVCTRGNXNVCT / RGNX
Capitalization197M732M27%
EBITDA-26.41M-120M22%
Gain YTD42.51487.06349%
P/E RatioN/AN/A-
Revenue0161M-
Total Cash35.4M274M13%
Total DebtN/A76.5M-
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
20
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVCTRGNX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
NVCT
Daily Signal:
Gain/Loss:
RGNX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSBRX62.370.26
+0.42%
Nuveen Dividend Growth I
CLEYX23.840.08
+0.34%
Columbia Cornerstone Equity Inst 3
AZMAX20.020.06
+0.30%
Virtus NFJ Emerging Markets Value A
LMIYX25.020.05
+0.20%
Lord Abbett Micro Cap Growth I
FICGX14.11N/A
N/A
Cantor Fitzgerald Large Cap Fcs Cl A

NVCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCT has been loosely correlated with MRVI. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCT jumps, then MRVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
+0.39%
MRVI - NVCT
33%
Loosely correlated
+0.30%
IBRX - NVCT
32%
Poorly correlated
+1.90%
RNAC - NVCT
31%
Poorly correlated
+5.13%
ADMA - NVCT
30%
Poorly correlated
+0.26%
RGNX - NVCT
29%
Poorly correlated
+0.77%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with VYGR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then VYGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
+0.77%
VYGR - RGNX
56%
Loosely correlated
+2.01%
SYRE - RGNX
56%
Loosely correlated
-0.54%
BEAM - RGNX
55%
Loosely correlated
+1.33%
DNLI - RGNX
53%
Loosely correlated
+1.07%
XNCR - RGNX
53%
Loosely correlated
-0.13%
More